Morning Overview on MSN
New prostate cancer immunotherapy cuts biomarkers by up to 99% in trial
A personalized peptide vaccine slashed prostate-specific antigen levels by as much as 99.6% in some men with advanced prostate cancer, according to a phase II clinical trial conducted at Kurume ...
Last month, former President Joe Biden announced that he had been diagnosed with an aggressive form of prostate cancer. The news sparked a larger conversation about what exactly the best practices are ...
Researchers found men who ejaculated more often had fewer prostate cancer diagnoses, pointing to a possible biological ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results